ACET - Adicet Bio, Inc.
IEX Last Trade
0.9192
0.000 0.044%
Share volume: 2,276
Last Updated: Fri 27 Dec 2024 08:27:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$0.92
0.00
0.04%
Summary score
25%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.96%
Return on assets
-12.28%
Return on sales
0%
Return on invested capital
197.06%
Total debt ratio
6.76%
Debt ratio change over timeo
-0.96%
Current Ratio
17.87%
Quick Ratio
0%
Cash Position Ratio
8.06%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.71%
Return on assets
-17.22%
Return on sales
0%
Return on invested capital
253.49%
Total debt ratio
7.79%
Debt ratio change over timeo
-0.97%
Current Ratio
17.13%
Quick Ratio
0%
Cash Position Ratio
12.12%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-7.91%
Return on assets
-7.6%
Return on sales
0%
Return on invested capital
188.46%
Total debt ratio
4.84%
Debt ratio change over time
-0.99%
Current Ratio
20.69%
Quick Ratio
0%
Cash Position Ratio
19.89%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-107.26%
Return on assets
-106.93%
Return on sales
0%
Return on invested capital
11.99%
Total debt ratio
-96.03%
Debt ratio change over time
-0.96%
Current Ratio
9.81%
Quick Ratio
0%
Cash Position Ratio
1.88%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ACET | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.96% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.28% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 197.06% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 6.76% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.96% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 17.13% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 12.12% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 15% | 32% | 32% |
| Short-term ratios | ACET | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -18.71% | -25.62% | 17.94% | 7.14% |
| Return on assets | -17.22% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 253.49% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 7.79% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.97% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 17.13% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 12.12% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 23% | 19% | 33% |